SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026)
SS Innovations International's (SSII) quarterly Income from Continuing Operations came in at -$2.7 million in Q2 2026, down 936.79% year-over-year from $318042.3 in Q2 2025, and up 25.71% quarter-over-quarter from -$3.6 million in Q1 2026.
Analysis
SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Income from Continuing Operations across 11 years of filings, most recently posting -$2.7 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations fell 936.79% year-over-year to -$2.7 million; the TTM figure through Jun 2026 stood at -$15.3 million (down 73.68% YoY), while the FY2025 annual figure was -$19.2 million, down 26.84% from the prior year.
- Income from Continuing Operations came in at -$2.7 million for Q2 2026 at SS Innovations International, up from -$3.6 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of -$80421.0 in Q1 2022 to a low of -$9.6 million in Q4 2023.
- Average Income from Continuing Operations over 5 years is -$3.0 million, with a median of -$2.6 million recorded in 2024.
- Year-over-year, Income from Continuing Operations plunged 1189.82% in 2023 and jumped 92.15% in 2025.
- Over 5 years, Income from Continuing Operations stood at -$812285.0 in 2022, then slumped by 1080.91% to -$9.6 million in 2023, then surged by 84.16% to -$1.5 million in 2024, then slumped by 253.47% to -$5.4 million in 2025, then soared by 50.45% to -$2.7 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were -$2.7 million in Q2 2026, -$3.6 million in Q1 2026, and -$5.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 201.00 Mn |
| 10 | SS Innovations International | 682.58 Mn | 660.28 Mn | 7.10 Mn | -2.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.66 Mn |
| Mar 31, 2026 | -3.58 Mn |
| Dec 31, 2025 | -5.37 Mn |
| Sep 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -256,691.00 |
| Mar 31, 2025 | -4.49 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -2.56 Mn |
| Jun 30, 2024 | -3.27 Mn |
| Mar 31, 2024 | -7.77 Mn |
| Dec 31, 2023 | -9.59 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | -4.36 Mn |
| Mar 31, 2023 | -1.04 Mn |
| Dec 31, 2022 | -812,285.00 |
| Sep 30, 2022 | -384,244.00 |
| Jun 30, 2022 | -395,175.00 |
| Mar 31, 2022 | -80,421.00 |
| Dec 31, 2021 | -353,735.00 |
| Sep 30, 2021 | -418,209.00 |